Search
for
Sort by
Research 871–900 of 1000+
- Synthetic Approaches for Pharmacologically Active Decorated Six-Membered Diazines
- Trastuzumab Induced Chemobrain, Atorvastatin Rescued Chemobrain with Enhanced Anticancer Effect and without Hair Loss-Side Effect
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
- The potential impact of melanosomal pH and metabolism on melanoma
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Effect of IGF-I on Hair Growth Is Related to the Anti-Apoptotic Effect of IGF-I and Up-Regulation of PDGF-A and PDGF-B
- Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930
- The influence of interferon on healthy and diseased skin
- Prophylaxis and Management of Skin Toxicities
- Application of Baricitinib in Dermatology
- Lrig1-expression confers suppressive function to CD4+ cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
- Hair Tissue Mineral Analysis and Metabolic Syndrome
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
- Phytotherapeutic Interventions using Rodent Models of Hair Loss: Current Research and Future Strategy
- 467 Novel selective phosphodiesterase inhibitors promote the adipogenic function of dermal fibroblasts: Implication to treat hair loss
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Regulatory Processes of the Canonical Wnt/β-Catenin Pathway and Photobiomodulation in Diabetic Wound Repair
- The Rho GTPase exchange factor Vav2 promotes extensive age-dependent rewiring of the hair follicle stem cell transcriptome
- Beneficial Effects of Deoxyshikonin on Delayed Wound Healing in Diabetic Mice
- Flavonoids and saponins: What have we got or missed?